Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Editas Medicine Achieves Milestone Under Juno Therapeutics Collaboration for Technical Progress Towards Overcoming the Tumor Microenvironment

Editas Medicine 08.09.2017

Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases

Editas Medicine 03.14.2017

Editas Medicine Extends CRISPR Genome Editing Leadership Through Licensing of New CRISPR Technologies

Editas Medicine 12.19.2016

Editas Medicine Expands Senior Management Team

Editas Medicine 10.03.2016

Editas Medicine Names Charles Albright as Chief Scientific Officer

Editas Medicine 08.22.2016

Editas Medicine Announces First Quarter 2016 Results and Update

Editas Medicine 05.16.2016

Editas Medicine Achieves Milestone under its Collaboration with Juno Therapeutics

Editas Medicine 05.04.2016

Editas Medicine Reports Fourth Quarter and Full Year 2015 Financial Results

Editas Medicine 03.30.2016

Editas Medicine Announces Closing of Initial Public Offering and Full Exercise of Option to Purchase Additional Shares

Editas Medicine 02.08.2016

Editas Medicine Announces Pricing of Initial Public Offering

Editas Medicine 02.03.2016

Loading